(Q36902632)

17 August 2017

1 reference

title

Drug treatment of Parkinson's disease (English)

1 reference

17 August 2017

1 reference

Quinn N

1

1 reference

PMC publication ID

2548944

17 August 2017

language of work or name

English

0 references

publication date

1 March 1995

1 reference

17 August 2017

1 reference

17 August 2017

310

1 reference

17 August 2017

6979

1 reference

17 August 2017

575-579

1 reference

Neurosurgical horizons in Parkinson's disease

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2548944

Drug treatment of Parkinson's disease: is "polypharmacy" best?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2548944

A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2548944

The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2548944

Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2548944

Onset and end-of-dose levodopa-induced dyskinesias. Possible treatment by increasing the daily doses of levodopa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2548944

"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2548944

Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2548944

Cholinergic-dependent cognitive deficits in Parkinson's disease.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2548944

Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2548944

Mood swings associated with the 'on-off' phenomenon in Parkinson's disease

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2548944

Dystonia in Parkinson's disease: clinical and pharmacological features

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2548944

Lisuride, a dopamine agonist in the treatment of early Parkinson's disease

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2548944

Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2548944

Catechol-O-methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patients.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2548944

The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport

4 September 2018

1 reference

12 December 2020

Protein redistribution diet restores motor function in patients with dopa-resistant "off" periods

1 reference

12 December 2020

Young onset Parkinson's disease

1 reference

12 December 2020

Clozapine in the treatment of psychosis in Parkinson's disease

1 reference

12 December 2020

Long-term bromocriptine treatment of de novo patients with Parkinson's disease. A seven-year follow-up

1 reference

12 December 2020

Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease

1 reference

12 December 2020

Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five years

1 reference

12 December 2020

The spectrum of levodopa-related fluctuations in Parkinson's disease

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.310.6979.575

1 reference

17 August 2017

1 reference

PMC publication ID

2548944

17 August 2017

PubMed publication ID

7888935

1 reference

PMC publication ID

2548944